| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | | 619 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | | 168 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | | 200 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | | 955 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | | 336 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | SUSPENSION / ORAL | | 6040 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | | 31885 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | | 320 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | | 70000 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, FOR SUSPENSION / ORAL | | 80 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | | 18790 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | | 35 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | | 4800 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | | 62 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | | 106 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | | 970 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET, EXTENDED RELEASE / ORAL | 352.63 mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | TABLET / ORAL | 183.94 mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET / ORAL | | 111 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | | 268 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | | 750 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, FILM COATED / ORAL | | 20 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | | 360 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | | 5400 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / ORAL | | 84 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | | 27768 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | | 8 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | | 2 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET / SUBLINGUAL | | 8 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | SUSPENSION / ORAL | | 160 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | | 308 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | | 312 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| CALCIUM PHOSPHATE | CALCIUM PHOSPHATE | 97Z1WI3NDX | POWDER, DENTIFRICE / DENTAL | 0.11 mg/mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | LOZENGE / ORAL | | 120 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | SOLUTION / ORAL | | 1451 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | | 81 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SUSPENSION / ORAL | | 570 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / SUBLINGUAL | | 36 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | | 145 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | | 6 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION, CONCENTRATE / INTRAVENOUS | | 60 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | | 166 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | ADJ PH | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 48 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | | 7560 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |